Back to Search

SETH HOLLENBACH, M.D.

M.D.

Urology Physician

NPI: 1437343845IndividualAccepts Medicare

Specialties, Licenses & Credentials

Urology PhysicianPrimary

Urology

Code: 208800000X

E6264(AR)

CMS Specialties

PrimaryUROLOGY

Education

UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE

Class of 2006

Research & Publications (20)

Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker.
PMID 12619891·Mol Cell Biochem·2003
8-other
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.
PMID 19297154·Bioorg Med Chem Lett·2009
4-observational
Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor.
PMID 15341941·Bioorg Med Chem Lett·2004
7-preclinical
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors.
PMID 15080981·Bioorg Med Chem Lett·2004
8-other
Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
PMID 15056002·J Med Chem·2004
7-preclinical
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors with improved functional activity.
PMID 15013007·Bioorg Med Chem Lett·2004
7-preclinical
Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs.
PMID 15013006·Bioorg Med Chem Lett·2004
7-preclinical
Short-term intravenous eptifibatide infusion combined with reduced dose recombinant tissue plasminogen activator inhibits platelet recruitment at sites of coronary artery injury.
PMID 14736451·J Am Coll Cardiol·2004
7-preclinical
Inhibition of purified factor Xa amidolytic activity may not be predictive of inhibition of in vivo thrombosis: implications for identification of therapeutically active inhibitors.
PMID 12750119·Arterioscler Thromb Vasc Biol·2003
4-observational
Design, synthesis, and structure-activity relationships of unsubstituted piperazinone-based transition state factor Xa inhibitors.
PMID 12639567·Bioorg Med Chem Lett·2003
7-preclinical
Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitors.
PMID 12565972·Bioorg Med Chem Lett·2003
7-preclinical
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice.
PMID 12368212·Am J Pathol·2002
7-preclinical
Identification of orally active, potent, and selective 4-piperazinylquinazolines as antagonists of the platelet-derived growth factor receptor tyrosine kinase family.
PMID 12166950·J Med Chem·2002
7-preclinical
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML).
PMID 12124172·Cancer Cell·2002
7-preclinical
Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
PMID 12097282·Cancer Res·2002
7-preclinical
Design, synthesis, and SAR of monobenzamidines and aminoisoquinolines as factor Xa inhibitors.
PMID 12039584·Bioorg Med Chem Lett·2002
7-preclinical
Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitors.
PMID 12031331·Bioorg Med Chem Lett·2002
4-observational
Discovery of transition state factor Xa inhibitors as potential anticoagulant agents.
PMID 11899247·Curr Top Med Chem·2001
6-review
Characterization of hOGG1 promoter structure, expression during cell cycle and overexpression in mammalian cells.
PMID 11765003·Adv Exp Med Biol·2001
7-preclinical
Age-related and tissue-specific accumulation of oxidative DNA base damage in 7,8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice.
PMID 11532868·Carcinogenesis·2001
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1662 HIGDON FERRY RD, SUITE 140
HOT SPRINGS, AR 71913

Location

Practice Location

1662 HIGDON FERRY RD, HOT SPRINGS, AR
(501) 525-4555

Quick Facts

NPI
1437343845
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
20
Publications
20

Are you this provider?

Claim Your Profile